On June 6, the Chinese medical website will receive the 22nd Chinese eye day on June 6, with the theme "eyes on the sun and prevention of myopia". Data shows, the incidence of juvenile myopia is as high as 50% ~ 60%, and 33% of the world people with myopia, far more than our country accounted for 22% of the total population of the world, constantly refresh record remind us: cherish eyes, is urgently needed. 

 

In recent years, the retail market share of eye medicines has been between 2.6 and 2.8 percent, according to data from the company. With the changing habits of life, the awareness of protecting eyes is improving, and the seemingly calm market for eye medicine is changing. 

 

According to different eye diseases, ophthalmic preparation has a variety of categories, which is used to dry eye strain, cataract disease, eye infections disease of ophthalmic drugs is larger, combined beyond the market share of eighty percent (see chart 1). 

 

 

 

A new breed of anti-fatigue and dry young stars is expected to lead the race 

 

The development of technology has made electronic products more popular, and mobile phones and computers have become basic necessities of life. Electronic products bring to people's work and life convenient at the same time, also greatly increased the burden of the eyes, eye fatigue has become one of the modern people daily disease. Anti-fatigue medicine occupy nearly forty percent of the ophthalmic medicine retail market, to compared with the other category, consumers are more willing to go to the pharmacy to buy medicine such products for self treatment. 

 

The market share of naphthalene eye drops has continued to lead in recent years (see chart 2). The variety is not hormone-free, and it works fast and is favored by patients. Although there are 25 enterprises in the variety of the products, only shandong province's doctor lun's eye drops are in the top five brands, and the competition is fierce. In dry anti-fatigue drugs on the market, shandong bausch has two sneak into the top five brands, enterprise in the competition advantage, targeted to enterprises on the market segmentation, not only a market for adult products such as ease of red blood silk ruddy LanRunJie jie and tends to alleviate eye fatigue, relieve eye fatigue and blurred vision children small embellish clean, etc. 

 

 

 

In recent years, the market share has gradually come to the top. Poly (vinyl alcohol) eye drops using single dose packaging, do not contain preservatives, can have the effect of artificial tears, have higher requirements on the production technology, especially the sealing technology and packaging material. In view of the limitations of domestic technology, at present the variety with only two factories, one is the hubei broad day dawn, polyvinyl alcohol eye drops accounted for about 90% of the market, the other is a taiwan-funded enterprises letter east biotech, although its share of the market temporarily is not high but has good growth (see chart 3). 

 

 

 

There is a variety of western medicine in cataract drugs 

 

Cataracts are one of the common eye diseases, and the elderly are high in cataracts. China's population is aging and the need for drug rigidity is increasing, and the market for cataract drugs is a place for many manufacturers. The data shows that cataract drugs account for nearly 30% of the eye's drug retail market, the second largest sub-class. 

 

Unlike other subclasses, the retail market for cataract drugs has its own characteristics, which is the same as the market share of the drug and the drug market (see figure 4). Cataract belong to the category of "circle" cataract "motherland medicine, Chinese medicine thought that the causes of age-related cataract is the elderly, kidney Yang deficiency, pixu (spleen deficient), JingXie losses," empty ", "sediment" for the pathogenesis of the disease, Chinese medicine treatment more than three dirty from the liver, kidney, spleen syndrome differentiation and treatment, has many advantages in terms of delay and treatment of cataract. 

 

 

 

Dial the cloud ingot, qi chrysanthemum rehmannia pill and musk bead eyes, eye drops are the main varieties, cataracts, proprietary Chinese medicine drugs in the first half of 2016 the three drug in cataract occupies twenty percent market share, and in the cataract of proprietary Chinese medicine compared with nearly fifty percent market share. Dial the cloud ingot is listed as national second-class Chinese medicine to protect species, the variety has two factories, including chuxiong old YunTang increased dramatically in recent years, in the first half of 2016 to occupy the cloud ingot of 90% or more of the market. In the past few years, the market share has been rising. 

 

It is the main product of cataract chemical medicine, with 52.5% market share in the first half of 2016 (see figure 5). The variety has eight factory, zhejiang Sally PuAi leads the market with absolute advantage, and continued growth over the past two years, cataract to further improve the concentration of drug market. Sally PuAi thought of marketing USES is "channel management", through to conduct knowledge lectures and public welfare activities, and continue to increase investment in advertising, make the products in the elderly patients have higher awareness (see figure 6). 

 

 

 

 

The change of the variety of resistant drugs was obvious 

 

To the hospital as a sales market of anti-infection drugs, in the retail market performance slightly smaller, and the resistance to limit, from 2013 to 2015 is given priority to with antibiotics of anti-infective drug ophthalmic drug use in the retail market share is declining, but some recovery during the first half of 2016. 

 

Anti-infective medicine retail market in the top five varieties, there are two varieties of the market share continued to rise in recent years, respectively, aureomycin eye ointment and levofloxacin hydrochloride eye drops. The growth of mycin hydrochloride (HCL) is mainly due to the expansion of the enterprise, and the growth is continuous. Levofloxacin is a left handed isomer of oxygen, and antibacterial activity is enhanced. Data show that in recent years in both the retail market and the hospital market, the market share of the levofloxacin eye drops are there is a growing trend, and ofloxacin eye drops is showed signs of slow decline. But as an established antimicrobial agent, it has its curative effect and price advantage, so the market share of the hydroxacin is still in the championship position. 

 

 

In a word, as one of facial features drug ophthalmic drugs, the reputation of its brand and product safety and comfort are equally important, so companies at the same time of getting the product publicity, good to control the quality of the products. In addition, the dosage form and packaging of ophthalmic drug use have certain effect to further excavate consumer's potential, the enterprise can be more diligent in this respect. Although ophthalmic drug market at present is still in the stage of development, but along with market competition intensifying, ophthalmic drugs will move around production enterprises and brands form a unique system, derive several strong driving force, niche market will present the trend of the market share advantage brand to the central, the competition will be intensified.